Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies.
In acute pancreatitis a toxic exudate accumulates within the peritoneal cavity, which contains activated pancreatic proteinases. Peritoneal lavage removes the exudate effectively, washing it away with large volumes of saline solution, but is of unproven therapeutic value and may have deleterious effects. These may be avoided by combining lower volume peritoneal washouts with intra-peritoneal installation of a proteinase inhibitor, although therapeutic effectiveness may be compromised by systemic absorption depending on the inhibitor selected. This latter effect was studied in fifteen patients with acute pancreatitis, treated by simple peritoneal washout and bolus intra-peritoneal administration of aprotinin (Trasylol) solution.
Larvin
M
M
University Department of Surgery, General Infirmary, Leeds, U.K.
Mayer
A D
AD
McMahon
M J
MJ
Müller-Esterl
W
W
Fritz
H
H
D000042:Absorption; D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D007611:Aprotinin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000188:drug therapy*; D013997:Time Factors
D007611:Aprotinin